Introduction {#sec1}
============

Genomic imprinting is a mammalian epigenetic phenomenon that causes a subset of genes to be monoallelically expressed according to their parental origin. These genes typically cluster together in 20--25 chromosomal regions in the mammalian genome containing genes exclusively expressed from the maternally or the paternally inherited alleles. Regulation of imprinting at these clusters relies on a *cis*-acting element known as imprinting center (IC), which exhibits parental-specific differences in CpG methylation inherited from the germline (reviewed in [@ref1],[@ref2]). Apart from the IC, other differentially methylated regions (DMRs) are also important for regulating imprinted expression of certain genes in the cluster. These DMRs, known as secondary DMRs, acquire differential methylation after the implantation stages of development and their methylation status and action is dependent hierarchically from the IC. That is, if the IC shows aberrant loss or gain of methylation, secondary DMRs show inappropriate loss or gain of methylation in the same parental allele ([@ref1],[@ref3]). The molecular mechanisms underlying hierarchical regulation between germline and secondary DMRs remain to be deciphered.

(Epi)genetic alterations at these imprinted regions cause congenital syndromes known as imprinting disorders. There are at least 12 of these syndromes that typically affect growth, development, metabolism and brain function ([@ref4]). The human chr15q11-q13 ([Fig. 1A](#f1){ref-type="fig"}) harbors an imprinted cluster of genes associated with two classical imprinted neurodevelopmental disorders, Angelman Syndrome (AS) (OMIM\#105830) and Prader--Willi Syndrome (PWS) (OMIM\#176270). Patients with AS are characterized by severe intellectual disability, developmental delay, seizure, ataxia and happy demeanor ([@ref5]). AS is caused by the loss of the maternally inherited copy of the E3 ubiquitin ligase *UBE3A* gene, which is expressed from both alleles in the majority of tissues, but exclusively expressed from the maternal allele in neurons ([@ref6],[@ref7]). Patients with PWS suffer from neonatal hypotonia and poor feeding initially, but children eventually develop hyperphagia-induced obesity and typically exhibit obsessive-compulsive behaviors. PWS is believed to be caused by the loss of two or more paternally expressed imprinted genes within the segment from *MKRN3* to the small nucleolar RNA (snoRNA) genes ([@ref8]) ([Fig. 1A](#f1){ref-type="fig"}). More recently, other diseases have been linked to this imprinted region, such as 15q11-q13 duplication syndrome (OMIM\#608636), characterized by intellectual disability and autistic spectrum disorder ([@ref9]), Schaaf-Yang syndrome (caused by paternally inherited *MAGEL2* mutations) (OMIM\#615547), which is phenotypically related to PWS and autism ([@ref10]) and central precocious puberty 2 (caused by paternally inherited *MKRN3* mutations) (OMIM\#615346) ([@ref11]).

![Stable imprinting of the chr15q11-q13 region in Ctrl and AS FIBs. (**A**) Scheme of the predictive epigenetic and transcriptional profile of the human chr15q11-q13 region in Ctrl and AS FIBs. Green rectangles, non-imprinted genes (\* indicates that *ATP10A* imprinting status is uncertain); blue rectangles, imprinted genes expressed from the paternal allele; red rectangles, imprinted genes expressed from the maternal allele; gray rectangles, non-expressed imprinted genes; the rectangle with blue and gray stripes represents neuronal-specific imprinted expression of the paternal *UBE3A* gene; AS-IC is highlighted in yellow; white lollipops, unmethylated DNA; black lollipops, fully methylated DNA; half black lollipops, partially methylated DNA; Pat, paternal allele; Mat, maternal allele; BP1 to 5, breaking points 1 to 5. (**B**) PWS-IC COBRA for Ctrl and AS FIBs. White circle, unmethylated band; half black circle, partially methylated band; black circle, fully methylated band. (**C**) Bisulfite sequencing analysis for PWS-IC in Ctrl and AS FIBs. Each line represents the methylation profile of an independent PCR amplicon as determined by Sanger sequencing and BiQ Analyser. White dots, unmethylated CpGs; black dots, methylated CpGs; Bsh1236I recognition sites used for PWS-IC COBRA are indicated; the numbers in brackets represent the number of times the same amplicon was sequenced; estimated number of bacterial clones obtained in the Luria-Bertani (LB) agar plates is indicated. (**D**) RT-qPCR analysis for *SNRPN* and *UBE3A* in Ctrl and AS FIBs. Relative expression has been normalized to the *GAPDH* housekeeping gene; data are the mean ± standard error of the mean (SEM) of at least three independent experiments; significant differences between Ctrl and AS FIBs are indicated with an asterisk as *P*-value \< 0.05, unpaired Student's *t*-test. (**E**) Allelic-specific *SNRPN* genomic and expression analysis in Ctrl FIBs assayed by Sanger sequencing. Yellow stripe indicates the rs705 SNP. (**F**) *UBE3A* nascent-transcript RNA FISH in Ctrl and AS FIBs. Percentage of biallelic/monoallelic *UBE3A* FISH signals was calculated by counting a minimum of 64 cells per sample.](ddy274f1){#f1}

Imprinting regulation within the chr15q11-q13 region is controlled by a bipartite IC composed of two elements: AS imprinting center (AS-IC) and PWS imprinting center (PWS-IC; reviewed in [@ref6]). AS-IC is an 880 bp region located 35 kb upstream of the binary *SNURF-SNRPN* promoter. AS-IC is postulated to drive transcription from upstream exons of the *SNURF-SNRPN* gene in the maternal germline to establish a CpG methylation imprint at the PWS-IC ([@ref12]). PWS-IC is situated on the promoter and exon 1 of the *SNURF-SNRPN* gene ([Fig. 1A](#f1){ref-type="fig"}). This region is methylated on the maternal allele and unmethylated on the paternal allele. The unmethylated paternal allele drives the expression of a polycistronic transcript which includes the *SNURF-SNRPN* pair, the non-coding transcript *IPW* and several snoRNAs on the distal part of the cluster ([Fig. 1A](#f1){ref-type="fig"}). In neurons, transcription continues further to produce the *UBE3A* anti-sense (*UBE3A-ATS*) long non-coding RNA which is believed to silence the paternal *UBE3A* allele ([@ref6],[@ref13]). The proximal part of the cluster is composed by several intronless genes exclusively expressed from the paternal chromosome, including the *MKRN3* and *NDN* genes. These two genes have differentially methylated CpG islands at their respective promoters which, like the PWS-IC, are unmethylated on the paternally inherited allele and methylated on the silent maternal allele ([@ref14],[@ref15]). Mutations or epimutations (changes in DNA methylation pattern) of the PWS-IC alter the epigenetic profile, including of the *NDN* and *MKRN3* DMRs, and allelic expression of the whole region ([@ref16],[@ref17]), confirming PWS-IC as the master regulator of imprinting of the PWS/AS region in somatic tissues. An exception to this was observed in two PWS patients with an unusual milder phenotype. These PWS patients presenting maternal uniparental disomy with methylated PWS-IC on both alleles have unexpected expression of a few imprinted genes commonly silenced in PWS, including *MKRN3*. This suggest that some relaxation on imprinting regulation governed by PWS-IC can occur at this 6 Mb imprinted cluster, at least, in a disease context ([@ref18]) suggesting that PWS/AS locus can be susceptible to independent epigenetic changes throughout the cluster.

In recent years, the emergence of the induced Pluripotent Stem Cell (iPSC) technology gave the unprecedented possibility to reprogram patient-derived somatic cells into stem-like cells to study a wide variety of human disorders ([@ref19]). In a disease context, patient-derived iPSCs can be differentiated into the affected cell-type or tissue to function as a disease cellular model. iPSCs can and have been also used for modeling imprinted diseases ([@ref20]). However, an important issue is whether ICs conserve their DMR status during the global epigenetic rewiring accompanying somatic reprogramming into iPSCs. Indeed, several reports have clearly pointed to the existence of multiple, but variable, imprinting defects in iPSCs ([@ref21]), although the molecular mechanisms causing these defects remain largely unknown. For instance, whether ICs remain as the elements that hierarchically control the epigenome of an entire imprinted cluster in iPSCs, as they normally do in somatic cells, has not been addressed.

iPSCs have been derived from patients with imprinted syndromes associated with the 15q11-q13 region ([@ref25]) to start unravelling molecular and cellular features associated with these syndromes ([@ref30],[@ref31]). Interestingly, PWS-IC methylation status is reported to be generally stable in these AS and PWS-derived iPSCs ([@ref25],[@ref27],[@ref30]). However, other studies reported a tendency for a certain degree of hypomethylation of the PWS-IC in normal or PWS-derived cells ([@ref23],[@ref32]), though the functional consequences of PWS-IC hypomethylation, if any, have not been addressed. Interestingly, genome-wide studies suggest that the promoter of *MKRN3* has a tendency to gain methylation in normal iPSCs ([@ref22],[@ref23]). Whether this is dependent or independent of the PWS-IC methylation status remains unknown.

By reprogramming skin fibroblasts with the Yamanaka factors from healthy and AS individuals, we generated two groups of isogenic iPSC lines (five lines from the healthy control individual and five lines from an AS patient). Interestingly, we could detect a maternal to paternal epigenotype switch at the PWS-IC in one of our control iPSCs. Such alteration has widespread consequences for the imprinting regulation of the locus. Interestingly, we also found that the PWS-IC loses its ability to influence epigenetic status of the *MKRN3* DMR, not only in our derived lines, but also in reported control and AS iPSCs. Our results indicate an alteration of the hierarchical influence of regulatory regions within imprinted loci in iPSCs which should be taken into consideration for disease modeling.

Results {#sec2}
=======

Correct imprinting status of the chr15q11-q13 in skin fibroblasts derived from a healthy donor and a patient with AS {#sec3}
--------------------------------------------------------------------------------------------------------------------

Fibroblasts from a 30-year-old female patient with AS and an age- and sex-matched healthy individual were derived from a punch skin biopsy and established in culture using standard conditions ([@ref33]). The patient with AS harbors a 4.8 Mb deletion of the maternal 15q11-q13 locus, between breaking points 2 and 3 (from *MKRN3* to *HERC2* genes, including *UBE3A*). Megadeletions, as this one, are the most common defects in AS, accounting for 70--80% of the cases ([@ref5]) ([Fig. 1A](#f1){ref-type="fig"}). To understand whether imprinting status was correctly maintained in the cultured fibroblasts, we analyzed the methylation status of the PWS-IC, the master regulator of imprinting at the 15q11-q13 region by combined bisulfite restriction analysis (COBRA) and bisulfite sequencing. For COBRA, genomic DNA was initially treated with sodium bisulfite to distinguish methylated from unmethylated CpGs. After amplification using a nested Polymerase Chain Reaction (PCR) approach ([@ref33]), a restriction enzyme was used to recognize three methylation-dependent retained sites within the PCR product ([Supplementary Material, Table S1](#sup1){ref-type="supplementary-material"}). AS fibroblasts (AS FIBs), as expected, only have an unmethylated allele, which was not cleaved by the restriction enzyme and corresponds to the single paternal allele. In contrast, in control fibroblasts (Ctrl FIBs) from the healthy donor, we could identify several bands that correspond to both fully methylated (three bands of similar size: 93, 110 and 115 bp), partially methylated (∼230 bp) and unmethylated (340 bp) alleles ([Fig. 1B](#f1){ref-type="fig"}). Presumably, the unmethylated band corresponds to the paternal allele, while both fully and partially methylated bands correspond to the maternal allele. These results were confirmed by bisulfite sequencing, a technique whereby post-PCR single amplicons are ligated, cloned and then sequenced to retrieve methylation information of several CpG dinucleotides within the PCR product. After ligation and cloning, there was a reduced number of bacteria colonies for AS FIBs compared to Ctrl FIBs in replicate experiments (AS FIBs \< 20 and Ctrl FIBs \> 200) ([Fig. 1C](#f1){ref-type="fig"}). Despite the clear cloning bias toward methylated amplicons in this assay, both unmethylated and methylated amplicons were observed for Ctrl FIBs, while only unmethylated amplicons were observed for AS FIBs ([Fig. 1C](#f1){ref-type="fig"}). All in all, these results suggest that cultured fibroblasts maintained the expected methylation status of PWS-IC.

We then explored the expression and imprinting profile of the paternally expressed *SNRPN* imprinted gene and the biallelically expressed *UBE3A* gene, both of which are absent from the maternal chromosome in AS FIBs ([Fig. 1A](#f1){ref-type="fig"}). The *SNRPN* levels were found to be equivalent between AS and Ctrl FIBs, while the levels of *UBE3A* were found to be at least 2-fold decreased in AS FIBs compared to Ctrl FIBs ([Fig. 1D](#f1){ref-type="fig"}), suggesting that absence of the expressing maternal copy results in around 50% decrease in *UBE3A* expression. To address the imprinted expression of *SNRPN* in Ctrl FIBs, we were fortunate to find the single nucleotide polymorphism (SNP) rs705 in the 5′UTR of *SNRPN* gene, allowing for allelic-specific expression analysis. While both nucleotides (T/C) could be detected at the deoxyribonucleic acid (DNA) level, only one of them (T) was detected at the complementary DNA (cDNA) level indicating that *SNRPN* is, as expected, monoallelically expressed ([Fig. 1E](#f1){ref-type="fig"}). In contrast to *SNRPN*, no SNP could be found in *UBE3A* exons (data not shown). Therefore, we developed a Stellaris™ *UBE3A* RNA Flourescent In Situ Hybridyzation (RNA FISH) ([@ref35]) using a probe detecting the *UBE3A* nascent transcript. As expected most of Ctrl FIBs (70.3%) have two fluorescent dots for *UBE3A*, while the vast majority of AS FIBs has only one dot (83.1%) ([Fig. 1F](#f1){ref-type="fig"}). These results suggest that the two *UBE3A* alleles in Ctrl FIBs and the single paternal copy of *UBE3A* in AS FIBs are expressed as expected, since *UBE3A* imprinting is only reported in neurons ([@ref6],[@ref7]). In conclusion, a profile consistent with the expected epigenetic and transcriptional landscape was maintained in cultured Ctrl and AS FIBs.

Creation of iPSCs from a healthy donor and a patient with AS {#sec4}
------------------------------------------------------------

To study the stability of imprinting at the chr15q11-q13 region in normal and in disease context, we reprogrammed both Ctrl and AS FIBs to obtain distinct iPSC lines. The creation of two set of isogenic lines, one from Ctrl FIBs and other from AS FIBs, greatly limits the influence of genetic factors on putative imprinting defects. Yamanaka reprogramming was performed using a lentiviral vector expressing the *OCT4*, *SOX2*, *KLF4*, *C-MYC* (OSKM) cassette plus a fluorescent tractable marker (dTomato) using a previously established protocol ([@ref36]). At the beginning of reprogramming, activation of the OSKM cassette could be followed with the dTomato fluorescent trackable marker (data not shown), which became silenced 3 weeks later as previously shown ([@ref36]). Five independent iPSC clones from both Ctrl and AS FIBs were isolated. They were initially cultured in feeder-dependent conditions, but adapted to feeder-free mTeSR1 conditions around passage 4, displaying embryonic stem cell (ESC)-like morphology and self-renewal capacities (data not shown). Karyotyping was done for the majority of the iPSC clones and found to be normal with the exception for Ctrl C and AS B iPSCs, which displayed a few chromosomal aberrations ([Supplementary Material, Fig. S1A](#sup1){ref-type="supplementary-material"}). iPSCs were then characterized for expression of stem cell factors by both immunofluorescence (IF) and Reverse Transcriptase-quantitative Polymerase Chain Reaction (RT-qPCR) analysis with more detailed analyses performed for the Ctrl E, Ctrl B and AS E iPSC lines. As expected, NANOG and SOX2 markers strongly stained all iPSC lines checked by IF ([Fig. 2A](#f5){ref-type="fig"}). Likewise, stem-cell markers (*OCT4*, *SOX2*, *NANOG* and *REX1*), but not the fibroblast marker *COL1A1*, were expressed as assessed by RT-qPCR in the same cells ([Fig. 2B](#f2){ref-type="fig"}). These results were confirmed by RT-qPCR analysis for the full panel of Ctrl and AS iPSCs and compared to the published AG1-0 iPSC line ([Supplementary Material, Fig. S1B](#sup1){ref-type="supplementary-material"}) which harbors a similar megadeletion to our AS iPSC lines ([@ref24]). These results confirmed that we successfully reprogrammed healthy and AS FIBs into five independent stem-like clones of cells.

![Stem-cell markers are expressed in Ctrl and AS iPSCs. (**A**) IF for SOX2 and NANOG (in red) in Ctrl B, Ctrl E and AS E iPSCs. Nuclei are marked with DAPI in blue; bar scale = 100 μm. (**B**) RT-qPCR analyses for the fibroblast marker (*COL1A1*) and the stem cell markers (*OCT4*, *SOX2*, *NANOG* and *REX1*) in Ctrl FIB, AS FIB, Ctrl B, Ctrl E and AS E iPSCs. Relative expression has been normalized to the *GAPDH* housekeeping gene; data are the mean ± SEM of at least two independent experiments*; COL1A1* RT-qPCR values were normalized to 1 for the Ctrl FIBs sample, while *OCT4*, *SOX2*, *NANOG* and *REX1* RT-qPCR values were normalized to 1 for the Ctrl E iPSC sample; significant differences toward the Ctrl FIBs sample are indicated with an asterisk as *P*-value \< 0.05, unpaired Student's *t*-test.](ddy274f2){#f2}

Reprogramming-induced methylation changes in PWS-IC cause loss of imprinting at the chr15q11-q13 {#sec5}
------------------------------------------------------------------------------------------------

To assess the stability of imprinting status of the chr15q11-q13 locus in normal and in disease context, we first analyzed whether the methylation status of the PWS-IC inherited from the initial Ctrl and AS FIBs was maintained upon reprogramming. For that, we performed COBRA for PWS-IC in the generated iPSC lines. All AS iPSC lines presented only the unmethylated paternal allele, preserving the methylation status inherited from AS FIBs ([Fig. 3A](#f3){ref-type="fig"} and [Supplementary Material, Fig. S2A](#sup1){ref-type="supplementary-material"}). Four of the Ctrl iPSC lines (Ctrl A, C, D & E) also maintained the inherited methylation pattern from Ctrl FIBs, presenting both an unmethylated band, presumably corresponding to the paternal allele, and partially and fully methylated bands, presumably corresponding to the maternal allele ([Fig. 3A](#f3){ref-type="fig"} and [Supplementary Material, Fig. S2A](#sup1){ref-type="supplementary-material"}). These results agree with previous studies demonstrating that methylation pattern at PWS-IC remains stable ([@ref25],[@ref27],[@ref30]). Interestingly, in contrast to the other Ctrl iPSC lines, Ctrl B iPSCs exhibit only the unmethylated band ([Fig. 3A](#f3){ref-type="fig"}). Since the nearby rs705 SNP of the *SNRPN* gene was still present in Ctrl B iPSC line ([Fig. 3C](#f3){ref-type="fig"}), a deletion of the PWS-IC was unlikely to explain this result. Instead, this data suggests a maternal-to-paternal epigenotype switch of the PWS-IC. Bisulfite sequencing confirmed the COBRA results: Ctrl B iPSC, like AS A iPSC, only had unmethylated amplicons, while Ctrl A iPSC had both methylated and unmethylated alleles (overrepresentation of methylated amplicons due to cloning bias as also found for Ctrl FIBs) ([Fig. 3B](#f3){ref-type="fig"}). To rule out that the putative loss of methylation on the maternal PWS-IC was not due to a global methylation loss, we decided to interrogate the methylation status of the IC from another imprinted region, the InterGenic-DMR (IG-DMR) of the *DLK1-MEG3* domain by COBRA. IG-DMR is known to be frequently hypermethylated in iPSCs ([@ref22],[@ref23]). We observed that in Ctrl B iPSC line, IG-DMR has the expected methylation pattern with both the presence of the unmethylated and methylated bands, ruling out an overall methylation defect in this line. Interestingly, a bias toward the methylation band (AS A, B, C & D), or complete reversal to a single methylated band was observed for the IG-DMR (Ctrl C & D) ([Fig. 3A](#f3){ref-type="fig"} and [Supplementary Material, Fig. S3A](#sup1){ref-type="supplementary-material"}), as previously found in iPSCs ([@ref22],[@ref23]).

![Loss of methylation at the maternal PWS-IC in Ctrl B iPSC results in loss of imprinting of genes at the chr15q11-q13. (**A**) PWS-IC and IG-DMR COBRA for Ctrl and AS FIBs and several iPSCs (Ctrl A, Ctrl B, Ctrl E; AS A and AS E). White circle, unmethylated band; half black circle, partially methylated band; black circle, fully methylated band. (**B**) Bisulfite sequencing analysis for PWS-IC in Ctrl A, Ctrl B and AS A iPSCs. Each line represents the methylation profile of an independent PCR amplicon as determined by Sanger sequencing and BiQ Analyser; white dots, unmethylated CpGs; black dots, methylated CpGs; Bsh1236I recognition sites used for PWS-IC COBRA are indicated; the numbers in brackets represent the number of times the same amplicon was sequenced; estimated number of bacterial clones obtained in the LB agar plate is indicated. (**C**) Allelic-specific *SNRPN* expression analysis assayed by Sanger sequencing for the Ctrl A, Ctrl B and AS E iPSCs. Yellow stripe indicates the rs705 SNP. (**D**) Nascent-transcript RNA FISH for *UBE3A* and *SNORD116* in Ctrl E, Ctrl B and AS E iPSCs. Percentage of biallelic/monoallelic *UBE3A and SNORD116* FISH signals was calculated by counting a minimum of 100 cells per sample.](ddy274f3){#f3}

The putative imprinting defect in Ctrl B iPSCs highlights the existence of methylation alterations at the level of PWS-IC in iPSCs. A tendency for decreased methylation at PWS-IC in certain iPSCs has been previously suggested ([@ref23],[@ref32]), however the functional consequences of such an alteration has never been explored. Taking advantage of the known exonic SNP (rs705) in the *SNRPN* gene, we asked whether loss of methylation at the maternal PWS-IC in Ctrl B iPSCs resulted in loss of imprinting, i.e. biallelic expression of the *SNRPN* gene. Indeed, allelic-specific Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) showed that *SNRPN*, which is paternally expressed in the normal Ctrl A, Ctrl D, AS D and AS E iPSCs, becomes biallelically expressed in Ctrl B iPSCs ([Fig. 3C](#f3){ref-type="fig"}; [Supplementary Material, Fig. S3B](#sup1){ref-type="supplementary-material"}). Moreover, nascent transcript RNA FISH for the *SNORD116* snoRNA cluster showed a switch from the monoallelic to the biallelic state in Ctrl B iPSCs, but not in normal Ctrl E or AS E iPSCs ([Fig. 3D](#f3){ref-type="fig"}). As expected expression of the *UBE3A* gene which is not imprinted in iPSCs remains biallelic in the Ctrl B and Ctrl E lines, and expressed from the sole paternal allele in the AS E line ([Fig. 3D](#f3){ref-type="fig"}). Importantly, the reported imprinting status in Ctrl B or in any other iPSCs was not altered in the range of cell passages we studied (passages 7--19). In conclusion, we found that one of the generated iPSCs lost methylation of the maternal PWS-IC and, as a consequence, displayed biallelic expression of the polycistronic RNA initiated from the promoter region where PWS-IC is situated.

PWS-IC fails to fully control the epigenetic landscape across the chr15q11-q13 in iPSCs {#sec6}
---------------------------------------------------------------------------------------

Imprinting dysregulation is a known side-effect of current iPSC reprogramming protocols, with many ICs switching their methylation patterns and causing loss of imprinting of the neighbouring genes ([@ref21]). However, whether ICs remain the imprinting master regulator within a cluster in iPSCs has never been functionally dissected. Taking advantage of our isogenic Ctrl iPSC lines with normal (Ctrl A, C, D & E) and abnormal (Ctrl B) methylation patterns at PWS-IC ([Fig. 3A](#f3){ref-type="fig"} and [B](#f3){ref-type="fig"}; [Supplementary Material, Fig. S3A](#sup1){ref-type="supplementary-material"}), we decided to explore the impact of these changes on the methylation profile of the two most-studied somatic DMRs (*NDN* and *MKRN3* DMRs) at the proximal part of the chr15q11-q13 region by COBRA. For the *NDN* DMR, we verified that the normal Ctrl E iPSC line exhibits the same band pattern as the Ctrl FIBs sample, with both a strong unmethylated and a weak methylated band ([Fig. 4A](#f4){ref-type="fig"}). In contrast, Ctrl B iPSCs only have an unmethylated band ([Fig. 4A](#f4){ref-type="fig"}), suggesting that the maternal allele fully lost its normal methylation. Through the presence of an exonic SNP at the *NDN* gene (rs2192206), we verified that *NDN* became biallelically expressed in Ctrl B iPSCs, remaining monoallelically expressed in Ctrl E iPSCs, as in the original Ctrl FIBs sample ([Fig. 4B](#f4){ref-type="fig"}). These results suggest a maternal-to-paternal epigenotype switch on the *NDN* DMR, similar to the changes at the level of the PWS-IC in Ctrl B iPSCs. Therefore, *NDN* DMR seems to be hierarchically dependent on the PWS-IC in iPSCs.

![*MKRN3* DMR, but not *NDN* DMR, is hypermethylated in Ctrl iPSCs**.** (**A**) *NDN* COBRA for Ctrl FIBs, Ctrl B and Ctrl E iPSCs. White circle, unmethylated band; black circle, methylated band. (**B**) Allelic-specific *NDN* expression analysis assayed by Sanger sequencing for Ctrl FIBs, Ctrl B and Ctrl E iPSCs. Yellow stripe indicates the rs2192206 SNP. (**C**) *MKRN3* COBRA for Ctrl FIBs and all the isogenic Ctrl iPSCs. White circle, unmethylated band; black circle, methylated band. (**D**) Bisulfite sequencing analysis for *MKRN3* DMR in Ctrl FIBs, Ctrl B and Ctrl E iPSCs. Each line represents the methylation profile of an independent PCR amplicon as determined by Sanger sequencing and BiQ Analyser; white dots, unmethylated CpGs; black dots, methylated CpGs; Bsh1236I recognition site used for *MKRN3* DMR COBRA is indicated; the numbers in brackets represent the number of times the same amplicon was sequenced; estimated number of bacterial clones obtained in the LB agar plates is indicated.](ddy274f4){#f4}

We then investigated the methylation pattern at the *MKRN3* DMR. While both a methylated and an unmethylated band were observed for Ctrl FIBs, we verified that, surprisingly, all the Ctrl iPSCs displayed a tendency for hypermethylation at the *MKRN3* DMR by COBRA ([Fig. 4C](#f4){ref-type="fig"}). This occurred independently of the methylation pattern at the PWS-IC, since the Ctrl B iPSC line also exhibits the same hypermethylation pattern as the other Ctrl iPSCs. This result was confirmed by bisulfite sequencing: while unmethylated and methylated amplicons were sequenced in the Ctrl FIBs sample, both Ctrl B and Ctrl E iPSCs showed a clear accumulation of hypermethylated amplicons ([Fig. 4D](#f4){ref-type="fig"}). Moreover, all the AS iPSCs lines also showed a tendency for *MKRN3* to become hypermethylated ([Supplementary Material, Fig. S3A](#sup1){ref-type="supplementary-material"}). All together, these results suggest that *MKRN3* DMR no longer responds to the PWS-IC methylation status and tends to become hypermethylated during iPSC reprogramming. This finding showed that iPSCs, in contrast to the donor somatic cells, exhibit a loss of hierarchical control of imprinting by PWS-IC in the chr15q11-q13 region. The reasons why some regions, such as the *MKRN3* DMR, but not others (e.g. *NDN* DMR) gain ectopic methylation during iPSC derivation need to be further explored. An interesting perspective is that the lack of the neuronal-specific *MKRN3* expression, but not of *NDN* (or *MAGEL2*) during reprogramming ([Supplementary Material, Fig. S3B](#sup1){ref-type="supplementary-material"}), might explain the aberrant gain of methylation on the paternal allele.

*MKRN3* DMR hypermethylation, independent of PWS-IC regulation, is a frequent event in iPSCs {#sec7}
--------------------------------------------------------------------------------------------

To corroborate the results obtained with our iPSC lines, we examined the methylation profile of both the PWS-IC and *MKRN3* DMR in five independent iPSC lines previously generated using different reprogramming methods ([Fig. 5A](#f5){ref-type="fig"}) ([@ref25],[@ref37]) (Silva *et al*., *in preparation*). This includes the AG1-0 line derived from an AS patient with a similar megadeletion to our AS iPSCs ([@ref25]). Using COBRA, we found the normal methylation pattern at the PWS-IC, with both unmethylated (corresponding to the paternal allele) and partially and fully methylated bands (corresponding to the maternal allele) in three out of the five previously generated iPSC lines ([Fig. 5B](#f5){ref-type="fig"}). As expected, the AG1-0 AS iPSC line only showed the sole unmethylated paternal allele, as previously found in all our derived AS iPSCs ([Fig. 3A](#f3){ref-type="fig"} and [Supplementary Material, Fig. S3A](#sup1){ref-type="supplementary-material"}). Interestingly, the iUC-DAND5_455/10 (iUC-DAND5 for short) iPSC line, with no genetic defects in chr15q11-q13, seems to have lost maternal methylation at the PWS-IC ([Fig. 5B](#f5){ref-type="fig"}), similar to the Ctrl B IPSC line ([Fig. 3A](#f3){ref-type="fig"}). This highlights for the fact that PWS-IC hypomethylation defects in iPSCs are more recurrent than initially appreciated.

![Hypermethylation of the *MKRN3* DMR is a frequent event in iPSCs and escapes control by the PWS-IC. (**A**) Summary table of the features of the five established iPSC lines used. (**B**) PWS-IC and *MKRN3* DMR COBRA in the five iPSC lines (and also in Ctrl FIBs for *MKRN3* DMR). White circle, unmethylated band; half black circle, partially methylated band; black circle, fully methylated band. (**C**) Scheme of the expected and the observed epigenetic and transcriptional profile of the human chr15q11-q13 region in Ctrl and AS iPSC lines. Blue rectangles, imprinted genes expressed from the paternal allele; red rectangles, imprinted genes expressed from the maternal allele; gray rectangles, silenced imprinted genes; white lollipops, unmethylated DNA; black lollipops, methylated DNA; Pat, paternal allele; Mat, maternal allele; green arrowheads highlight the epigenetic errors found; iPSCs lines in black correspond to the lines generated in this study; iPSCs in red correspond to the previously published IPSC lines.](ddy274f5){#f5}

We then verified the methylation pattern of the *MKRN3* DMR in these iPSCs. In four out of the five iPSCs, including AG1-0, a clear tendency for hypermethylation at the level of the *MKRN3* DMR is observed. This demonstrated that *MKRN3* DMR hypermethylation is indeed frequent in iPSCs regardless of the reprogramming procedure. As described for the Ctrl B iPSC line, hypomethylation of the maternal PWS-IC in the iUC-DAND5 iPSC did not impact the gain of methylation at the *MKRN3* DMR ([Fig. 5B](#f5){ref-type="fig"}). Only the iPSC6.2 line was found to have both the unmethylated and methylated alleles (with some bias toward the unmethylated allele). Overall, by using established iPSC lines, we confirmed the results from our isogenic system. Indeed, we confirmed that *MKRN3* DMR hypermethylation and loss of hierarchical control of the IC of the Prader--Willi/Angelman imprinted cluster are frequent events occurring upon reprogramming into iPSCs (summarized in [Fig. 5C](#f5){ref-type="fig"}).

Discussion {#sec8}
==========

Imprinting defects are known to accumulate in iPSCs ([@ref21]); however, the frequency and causes underlying these defects remain to be understood. In particular, it is not known whether imprinting dysregulation is driven only by epigenetic changes in the ICs or whether epigenetic alterations in other regions could also account for imprinting errors accumulated during reprogramming. In this study, we evaluated the impact of Yamanaka reprogramming in the imprinting regulation of the PWS/AS region on chr15q11-q13. We found that PWS-IC, the master regulator of chr15q11-q13 imprinting, is mostly resistant to changes in its parental-inherited methylation profile. However, loss of maternal methylation was found in one derived and one published iPSC lines. Loss of maternal methylation at the PWS-IC caused loss of imprinting of many genes within the cluster. Interestingly, PWS-IC lost the ability to control differential methylation at the *MKRN3* DMR, which showed a propensity to gain aberrant methylation in iPSCs. These results highlight, for the first time, a change in the hierarchy of imprinting regulation within imprinted domains in iPSCs.

Skin fibroblasts in culture seem to maintain their methylation profiles intact across the chr15q11-q13 in both Ctrl and AS FIBs ([Fig. 1](#f1){ref-type="fig"}). We cannot completely rule out for undetectable imprinting defects in a minority of fibroblasts, since we have not performed single-cell analysis (except for *UBE3A* nascent-transcript RNA FISH). In any case, these results are in agreement with previous publications, suggesting stable imprinting in cultured skin fibroblasts ([@ref25],[@ref27]). To generate isogenic Ctrl and AS iPSC lines, we used a standardized lentiviral approach ([@ref36]) for somatic reprogramming, which has been previously used to generate AS iPSCs carrying *UBE3A* mutations ([@ref27]). We confirmed that our five isogenic AS and five isogenic Ctrl iPSCs have ESC-like morphology, self-renewal capacity, express stem cell markers and mostly have a normal karyotype ([Fig. 2](#f2){ref-type="fig"} and [Supplementary Material, Fig. S2](#sup1){ref-type="supplementary-material"}). The use of independent but genetically identical iPSCs lines provided a good starting point to study the epigenetic stability of the PWS/AS imprinting cluster in both healthy background and disease context.

We began by addressing the status of PWS-IC in the different iPSCs. We detected that the karyotypically normal Ctrl B iPSC line lost methylation on the maternal allele, while the paternal allele remained unmethylated in both Ctrl and AS iPSCs ([Fig. 3A](#f3){ref-type="fig"} and [Supplementary Material, Fig. S2A](#sup1){ref-type="supplementary-material"}). Loss of methylation at the PWS-IC was also seen in the IUC-DAND5 iPSC line ([Fig. 5B](#f5){ref-type="fig"}), suggesting that the maternal PWS-IC has some propensity to lose methylation during reprogramming, while the paternal PWS-IC seems to remain unmethylated and inert to methylation aberrations. This data contrasts with previous studies reporting a stable parental-inherited methylation pattern in healthy, AS and PWS iPSCs for PWS-IC ([@ref25],[@ref27],[@ref30]). However, our results corroborate other findings reporting partial hypomethylation of the PWS-IC in normal or PWS-derived iPSCs ([@ref23],[@ref32]). A direct implication of this is that AS iPSCs derived from patients with megabase deletions (65--70% of patients with AS) ([@ref5]) with only the unmethylated paternal PWS-IC are less likely to accumulate imprinting errors at this element and, thus, might provide a good cellular system to model AS. In contrast, PWS iPSCs derived from patients with megabase deletions (70--80% of patients with PWS) ([@ref8]) containing only the methylated maternal PWS-IC will be prone to hypomethylation defects with possible consequences in imprinting regulation of the locus. In any case, independently of acquiring reprogramming-induced imprinting defects or not, the methylation profile of iPSCs remains thereafter stable through cell passage and cell differentiation (data not shown) ([@ref23],[@ref30]). Nevertheless, our results suggest that recurrent screening for methylation errors at the level of PWS-IC should be advised in iPSCs used to study diseases affecting the chr15q11-q13 region.

Given the observed maternal-to-paternal epigenotype switch in the PWS-IC in Ctrl B iPSCs ([Fig. 3A](#f3){ref-type="fig"}), we explored the extent to which imprinting of the chr15q11-q13 region was affected. We observed that genes within the polycistronic transcript initiated at the PWS-IC, such as *SNRPN* and *SNORD116* genes, became biallelically expressed ([Fig. 3C](#f3){ref-type="fig"} and [D](#f3){ref-type="fig"}). Loss of imprinting was also seen for the *NDN* gene, which lies on the proximal part of the domain. This was accompanied by the loss of maternal methylation at the *NDN* DMR ([Fig. 4A](#f4){ref-type="fig"} and [B](#f4){ref-type="fig"}). Overall, we report, for the first time in iPSCs, that loss of maternal PWS-IC has widespread effects on imprinting regulation of the chr15q11-q13 region. Interestingly, around 3% of AS cases arise from similar imprinting defects resulting in loss of maternal methylation of the PWS-IC ([@ref5]). In principle, such a reprogramming-induced imprinting defect can be used to model the cases of AS caused by loss of maternal methylation at the PWS-IC, a distinct molecular mechanism causing the disease from the megabase deletions or mutations in the *UBE3A* gene.

A surprising finding from our study was the fact that in contrast to the *NDN* DMR, the *MKRN3* DMR does not respond to alterations in the PWS-IC methylation status ([Fig. 5B](#f5){ref-type="fig"}). Moreover, a clear tendency to become hypermethylated was seen, not only in all our healthy and AS-derived iPSCs, but also on previously established iPSCs, with only one exception (the iPSC6.2 line) ([Fig. 4C](#f4){ref-type="fig"} and [D](#f4){ref-type="fig"}; [Fig. 5B](#f5){ref-type="fig"}; [Supplementary Material, Fig. S3A](#sup1){ref-type="supplementary-material"}). These results confirm unexplored reports on *MKRN3* DMR hypermethylation in iPSCs previously gathered from genome-wide studies ([@ref22],[@ref23]). To our knowledge, *MKRN3* DMR hypermethylation has never been observed in any other tissues or cell types. Furthermore, our findings clearly point toward a loss of the hierarchical regulation of imprinting at the chr15q11-q13, a situation only reported once before in two PWS patients with milder phenotype ([@ref18]). Indeed, PWS-IC no longer exerts its master imprinting regulator role as it normally does in somatic cells ([@ref16],[@ref17]). The reasons why changes in the hierarchy of imprinting regulation for the chr 15q11-q13 occur in iPSCs remains to be understood. It is also unclear why *MKRN3* DMR gains methylation, while the same is not observed for *NDN* DMR. A possible explanation centers on the fact that *MKRN3*, in contrast to *NDN,* is silent from both alleles and presumably becomes prone to acquire methylation on the unmethylated, albeit silenced, paternal allele. This likely occurs during the reprogramming process since the *MKRN3* DMR remains differentially methylated in fibroblasts, despite the fact that *MKRN3* gene is also not expressed in this cell type. Further studies will be necessary to understand the role of the initial cell source (the only iPSC line with no *MKRN3* hypermethylation was derived from CD34+ progenitors) ([Fig. 5A](#f5){ref-type="fig"} and [B](#f5){ref-type="fig"}) or of reprogramming methods on the aberrant hypermethylation of the *MKRN3* DMR in many iPSCs.

By exploring the mechanisms of imprinting regulation at the PWS/AS imprinted cluster in depth, we documented several anomalies on methylation pattern and unravelled changes in the hierarchy of imprinting regulation in iPSCs. Whether imprinting defects at other clusters (e.g. *DLK1-DIO3* cluster is also affected in some of our iPSC lines) might also lead to changes in the imprinting regulatory principles documented for normal somatic cells will need to be explored in the future. In any case, our study clearly suggests that imprinting defects in iPSCs might also occur in somatic or secondary DMRs, regardless of epigenetic alterations at the respective IC. This increases the current spectrum of imprinting defects associated to this cell type likely to cause loss of imprinting for certain gene(s) within an imprinted cluster. This also highlights for the need to screen for epigenetic defects in all imprinting regulatory regions within a cluster and not only at the IC. Interestingly, by presenting such flexibility of imprinting regulation, iPSCs might become a good cellular model to study the relationships between regulatory elements within an imprinted domain to achieve long-range transcriptional regulation. Finally, the impact these hierarchical changes of imprinting regulation will have on iPSC differentiation toward committed lineages will certainly be an important issue to explore in the future in order to improve the use of iPSCs for disease modeling.

Materials and Methods {#sec9}
=====================

Patient-derived fibroblasts {#sec10}
---------------------------

Fibroblast punch biopsies from both the patient with AS and the age- and sex-matched individual were collected in Hospital de Santa Maria (Centro Hospitalar Lisboa Norte) in accordance with European and National ethical regulation and approved by the Ethical Committee of Instituto de Medicina Molecular João Lobo Antunes (iMM) and Hospital de Santa Maria. For the Ctrl individual, written informed consent was obtained. For the patient with AS, written informed consent was obtained from the patient's legal guardians. Isolation and maintenance of fibroblasts were performed according to a standardized protocol ([@ref33]). For AS FIBs, a 4.8 Mb deletion of the 15q11-q13 between breaking points 2 and 3 (from *MKRN3* to *HERC2* genes) was confirmed using a chromosomal array CGH 180K (performed by Serviço de Genética, Departamento de Patologia, Faculdade de Medicina, Universidade do Porto). Human fibroblasts were maintained in DMEM supplemented with 10% fetal bovine serum, 1 m[m]{.smallcaps} L-Glutamine, and 100 units/ml penicillin, 100 μg/ml streptomycin using products from Life Technologies in a humid incubator at 37°C with 5% (vol/vol) CO~2~.

Yamanaka reprogramming {#sec11}
----------------------

iPSC reprogramming of AS and Ctrl FIBs was performed using a previously published protocol ([@ref36]). Briefly, pluripotency of adult human AS and Ctrl FIBs was induced with a polycistronic lentiviral vector encoding for the reprogramming OSKM cassette and a red fluorescent protein (*dTomato*) under the spleen focus-forming virus promoter ([@ref36]). Transduced fibroblasts were harvested via trypsinization and transferred onto mouse embryonic fibroblasts (MEFs) 3 days after transduction and thereafter cultured in human embryonic stem cell (hES) medium composed by DMEM F-12 (Gibco, Invitrogen), 15% Knock-out serum replacement, 1 m[m]{.smallcaps} L-glutamine (Gibco, Invitrogen), 0.1 m[m]{.smallcaps} nonessential amino acids (Sigma-Aldrich), 100 μM β-mercaptoethanol (Sigma-Aldrich), 100 units/ml penicillin, 100 μg/ml streptomycin (Gibco, Invitrogen) and 10 ng/ml of basic Fibroblast Growth Factor (bFGF; Peprotech). From day 21 of reprogramming, the first ESC-like colonies appear and single colonies were picked based on morphology and further expanded on a MEF feeder layer. A total of five iPSC lines derived from AS and Ctrl FIBs each were obtained.

iPSC culture {#sec12}
------------

iPSCs were initially expanded in hES medium under MEF feeder-dependent conditions. When colonies reached 50--75% confluency, cells were passed with a splitting ratio from 1:2 to 1:4 using 0.5 m[m]{.smallcaps} EthyleneDiamineTetraacetic Acid (EDTA) in Phosphatase Buffered Saline (PBS), avoiding single-cell suspensions. Medium was changed every day. After two/three passages without or with minimal spontaneous differentiation in feeder-dependent conditions, cells were transferred to Matrigel (Corning)-coated plates in mTeSR1 (STEMCELL Technologies) medium supplemented with 50 units/ml penicillin, 50 μg/ml streptomycin (Life Technologies), using the same enzyme-free method. Medium was changed every day. Cells were passaged at least twice in feeder-free conditions before any experiment was performed.

DNA methylation analysis {#sec13}
------------------------

Genomic DNA was purified using conventional phenol:chloroform:isoamyl alcohol extraction. Bisulfite treatment was performed using the EZ DNA Methylation Gold Kit (Zymo Research) following manufacturer's guidelines. Bisulfite treated DNA was amplified by PCR (*MKRN3* DMR and *NDN* DMR) or nested PCR (PWS-IC and IG-DMR) using the primers and conditions summarized in [Supplementary Material, Table S1](#sup1){ref-type="supplementary-material"}. For COBRA, PCR products were extracted from the agarose gel using the NZYGelpure kit (NZYTech) and then submitted to a restriction digest with BstUI/Bsh1236I (Thermo Fisher) to distinguish methylated from unmethylated alleles based on the original status of the CGCG sequence. For bisulfite sequencing of the PWS-IC and the *MKRN3* DMR, PCR products were cloned into the pGEM-T Easy vector (Promega) and at least 10 clones from each sample were sequenced. Methylation analysis was performed using BiQ Analyser ([@ref40]).

RT-qPCR {#sec14}
-------

Total RNA was isolated from fibroblasts, iPSCs and brain cortex using NYZol (NZYtech) and then DNAse I treated (Roche) to remove contaminating DNA. RNA template was reverse transcribed using the Transcriptor High Fidelity cDNA Synthesis Kit (Roche), according to the manufacturer's instructions for RT-qPCR. cDNA was subjected to qPCR with iTaq^TM^ SYBR® Green Supermix (Bio-Rad) in a ViiA7 Applied Biosystems machine, according to the manufacturer's instructions using the primers in [Supplementary Material, Table S2](#sup1){ref-type="supplementary-material"}.

RT-PCR {#sec15}
------

cDNA was subjected to PCR to study *MKRN3*, *NDN*, *MAGEL2* and *GAPDH* expression. The primer pairs and PCR conditions are described in [Supplementary Material, Table S2](#sup1){ref-type="supplementary-material"}.

Allelic-specific expression analysis {#sec16}
------------------------------------

Primers were designed to amplify genomic regions around frequent exonic SNPs in the human population for several genes within chr15q11-q13 imprinted cluster (data not shown). SNPs for *SNRPN* (rs705) and *NDN* (rs2192206) genes were found in the Ctrl samples. cDNA collected from Ctrl FIBs and Ctrl A, Ctrl B, Ctrl E and/or AS E iPSC samples were then amplified by PCR and the product was sequenced to determine the monoallelic or biallelic status of these genes. Primers for PCR and sequencing and respective PCR conditions are in [Supplementary Material, Table S2](#sup1){ref-type="supplementary-material"}.

RNA FISH {#sec17}
--------

In order to analyze *UBE3A* allelic-specific expression in Ctrl FIBs, AS FIBs and Ctrl B, Ctrl E and AS E iPSCs, custom Stellaris™ RNA FISH probes designed using the Stellaris™ Probe Designer software (Biosearch Technologies). The dye used was Quasar® 570 and the region used for the design of the probe was Chr15:25353077-25360996 (GRCh38.p7). Probe sequences are in [Supplementary Material, Table S3](#sup1){ref-type="supplementary-material"}. Cells were cultured to 75% confluency and hybridization conditions for RNA FISH were followed according to Stellaris™ guidelines using a final concentration of 125 nM of probe per coverslip.

For *SNORD116* RNA FISH probe, a RP11-186C7 bacterial artificial chromosome (BAC; BACPAC Resources Center) was prepared using the Nick Translation Kit (Abbot) with Green dUTP (Enzo Life Sciences). RNA FISH was done accordingly to established protocols ([@ref41]) in Ctrl B, Ctrl E and AS E iPSCs. After the RNA FISH procedure for both probes, nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich), diluted 1:5000 in 2× Saline Sodium Citrate (SSC) buffer for 5 min at room temperature (RT) and mounted with Vectashield Mounting Medium (Vectorlabs). Cells were observed with the widefield fluorescence microscope Zeiss Axio Observer (Carl Zeiss MicroImaging) with 63× oil objective using the filter sets FS43HE, FS38HE and FS49. Digital images were analyzed with the FIJI platform ([@ref42]). *UBE3A* and *SNORD116* fluorescent signals were counted in at least 64 cells of FIBs and at least 100 cells of iPSCs.

IF {#sec18}
--

iPSCs were cultured in Matrigel-coated glass coverslips to 75% confluency. Cells were washed with PBS and fixed with 3% ParaFormAldehyde (PFA) for 10 min at RT, permeabilized with 0.5% Triton 100× (Sigma-Aldrich) in PBS on ice for 5 min and incubated for 15 min at RT in blocking solution containing 1% Bovine Serum Albumin (Sigma-Aldrich) in PBS. The cells were stained with the primary antibody diluted in blocking solution according to [Supplementary Material, Table S4](#sup1){ref-type="supplementary-material"} for 45 min in a humid chamber. Cells were then incubated with the secondary antibody Cy™3 AffiniPure F(ab\')~2~ Fragment Goat Anti-Mouse IgG (H+L) (dilution 1:200; Jackson ImmunoResearch Laboratories Inc.) for 45 min. DAPI (0.2 mg/ml) was used to stain the DNA and mark the nuclei by incubating at RT for 2 min. Mounting and imaging was performed as stated for RNA FISH.

Karyotyping {#sec19}
-----------

iPSCs were expanded until they have reached the logarithmic phase (70% confluency). Colcemid was added to the cell medium at 10 μl/ml and cells were incubated in a humid incubator at 37°C with 5% (vol/vol) CO~2~ for 4 h. Cells were detached with accutase, centrifuged at 300 g for 3 min and washed with PBS three times. Cells were then incubated with 55 m[m]{.smallcaps} of KCl at 37°C for 30 min. After centrifugation for 15 min at 400 g, most of the supernatant was removed and only 1 ml of supernatant was left for resuspending the cells. Fixative solution (3:1 ratio of methanol:glacial acetic acid) was added dropwise and the mixture was incubated on ice for 10 min. After centrifugation at 400 g, most of the supernatant was removed and only 1 ml of supernatant was left for resuspending the cells. The steps of adding fixative solution, incubation on ice and centrifugation were repeated three more times and the nuclei were stored at −20°C before G-banding karyotype (performed by GenoMed, Diagnósticos de Medicina Molecular SA).
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======================
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